Veracyte Inc (VCYT)
21.02
+0.10
(+0.48%)
USD |
NASDAQ |
May 07, 15:16
Veracyte Profit Margin (Quarterly): -28.81% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -28.81% |
| September 30, 2023 | -32.87% |
| June 30, 2023 | -9.30% |
| March 31, 2023 | -9.82% |
| December 31, 2022 | -4.79% |
| September 30, 2022 | -11.54% |
| June 30, 2022 | -13.08% |
| March 31, 2022 | -21.33% |
| December 31, 2021 | -15.64% |
| September 30, 2021 | -23.40% |
| June 30, 2021 | -16.40% |
| March 31, 2021 | -114.1% |
| December 31, 2020 | -23.29% |
| September 30, 2020 | -13.25% |
| June 30, 2020 | -53.25% |
| March 31, 2020 | -37.65% |
| December 31, 2019 | -25.09% |
| September 30, 2019 | -2.36% |
| June 30, 2019 | -8.28% |
| March 31, 2019 | -6.49% |
| December 31, 2018 | -12.06% |
| September 30, 2018 | -19.04% |
| June 30, 2018 | -27.46% |
| Date | Value |
|---|---|
| March 31, 2018 | -45.79% |
| December 31, 2017 | -43.06% |
| September 30, 2017 | -40.24% |
| June 30, 2017 | -39.65% |
| March 31, 2017 | -50.01% |
| December 31, 2016 | -24.12% |
| September 30, 2016 | -30.30% |
| June 30, 2016 | -76.61% |
| March 31, 2016 | -74.35% |
| December 31, 2015 | -57.06% |
| September 30, 2015 | -72.52% |
| June 30, 2015 | -76.72% |
| March 31, 2015 | -67.84% |
| December 31, 2014 | -66.74% |
| September 30, 2014 | -80.32% |
| June 30, 2014 | -76.70% |
| March 31, 2014 | -89.27% |
| December 31, 2013 | -86.17% |
| September 30, 2013 | -112.7% |
| June 30, 2013 | -128.1% |
| March 31, 2013 | -157.3% |
| December 31, 2012 | -108.5% |
| September 30, 2012 | -153.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-114.1%
Minimum
Mar 2021
-2.36%
Maximum
Sep 2019
-24.43%
Average
-16.40%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 14.81% |
| XWELL Inc | -88.94% |
| ProPhase Labs Inc | -250.1% |
| Applied DNA Sciences Inc | -124.0% |
| OncoCyte Corp | -5.09K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.97% |
| Return on Assets | -6.51% |
| Return on Invested Capital | -6.97% |
| Gross Profit Margin (Quarterly) | 70.09% |
| Operating Margin (Quarterly) | -3.03% |
| Return on Net Operating Assets | -8.00% |